Highlights Realcan Pharmaceutical Group Co., Ltd.

Equities

002589

CNE1000013X5

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-23 EDT			5-day change	1st Jan Change
2.16 ^CNY	-5.26%		-4.85%	-33.94%

04-29	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Realcan Pharmaceutical Group Co., Ltd. Implements 2023 Final Profit Distribution for A Shares, Payable on 04 June 2024	05-28	CI
Shenzhen New Nanshan Holding Co., Ltd. Approves Cash Dividend for the Year 2023	05-21	CI
Realcan Pharmaceutical Group Co., Ltd. Proposes the Profit Distribution for 2023	04-29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Pharmaceutical Co., Ltd. entered into an agreement to acquire 51% stake in Hunan Runji Pharmaceutical Co., Ltd. from Realcan Pharmaceutical Group Co., Ltd. for CNY 149 million	23-01-16	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million.	22-12-15	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 22, 2022	22-07-14	CI
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-24	CI
Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021	22-05-05	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million.	22-02-17	CI
Realcan Pharmaceutical Group Co., Ltd. acquired Health Technology for approximately CNY 230 million.	22-02-16	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Realcan Pharmaceutical Group Co., Ltd. Announces Cash Dividend on A Shares for the Year 2020, Payable on June 23, 2021	21-06-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Realcan Pharmaceutical Group Co., Ltd.

Equities

002589

CNE1000013X5

Highlights

Filters